Target intelligence / Profile preview

Multiple immune cell types and associated cytokine pathways

Molecular classification
Other
01

Overview

Multiple immune cell types and associated cytokine pathways refer to the integrated network of various leukocyte populations and the signaling proteins they utilize to mediate host defense and inflammatory responses. This system involves diverse cell populations, including T cells, B cells, macrophages, and dendritic cells, which communicate through a vast array of cytokines such as interleukins and interferons (Janeway's Immunobiology, 9th edition). In healthy states, these pathways maintain homeostasis and respond to pathogens, but their dysregulation is central to the pathogenesis of autoimmune diseases, chronic inflammation, and cancer (Nature Reviews Immunology, 2018). Therapeutic strategies often aim to modulate this network, either through broad-spectrum immunosuppressants like glucocorticoids or through targeted biologics that neutralize specific cytokines or block their receptors (StatPearls, 2023). Because this term encompasses a wide variety of distinct molecular entities and cellular processes, it is classified as a biological system rather than a single, discrete therapeutic target. Monitoring these pathways often involves measuring systemic inflammatory markers or specific cytokine levels to assess disease activity and treatment response (PubMed, PMID: 30272093). Safety concerns associated with modulating these pathways primarily revolve around the risk of opportunistic infections and impaired immune surveillance.

Other names
Immune system networkCytokine signaling networkInflammatory pathwaysLeukocyte-cytokine axis
02

Mechanism of action

Broad or specific modulation of leukocyte activity and cytokine-mediated signaling to suppress pathological inflammation or enhance anti-tumor immunity.

03

Biological functions

Immune responseSignal transductionCell proliferationApoptosisCell-to-cell communication
04

Disease associations

InflammationAutoimmune diseaseCancerInfectionAllergy
05

Safety considerations

Increased risk of serious opportunistic infectionsReactivation of latent tuberculosisPotential for malignancy due to impaired immune surveillanceInfusion or injection site reactionsNeutropenia or lymphopenia
06

Interacting drugs

Prednisone

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6) levelsTumor necrosis factor-alpha (TNF-alpha) levelsAbsolute lymphocyte countErythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Multiple immune cell types and associated cytokine pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple immune cell types and associated cytokine pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call